News Releases

MONTREAL MAYOR GÉRALD TREMBLAY JOINS BRISTOL-MYERS SQUIBB IN PRESENTING TREES TO LOCAL SAINT-LAURENT SCHOOLS

A unique green way to inaugurate company's new offices in Montreal's Technoparc

 

28/05/09

MONTREAL, CANADA – (May 28, 2009) – Bristol-Myers Squibb Canada (“BMS”) celebrated the opening of its new national head offices today with a unique green twist.

Montreal Mayor, Gérald Tremblay joined Dieter Weinand, President, Intercontinental, Bristol-Myers Squibb Company and Wayne Quigley, President and General Manager, Bristol-Myers Squibb Canada, in presenting trees to students from local primary schools as a symbol of the company's roots in the Borough of Saint-Laurent and its commitment to the community.

With the official opening of its new Technoparc offices, BMS begins a new chapter in its proud 57-year history in the vibrant Saint-Laurent business community. Many local dignitaries and business leaders were in attendance to celebrate the official opening and Bristol-Myers Squibb's commitment to bringing new vitality to the community where staff members work and live. The occasion was marked with a symbolic tree-planting ceremony at the new head office, a ribbon-cutting ceremony and a reception.

“Bristol-Myers Squibb is proud to be part of the Saint-Laurent community and we look forward to this new chapter in the future of BMS,” said Wayne Quigley, President and General Manager, Bristol-Myers Squibb Canada. “The official opening of our new location represents a renewal of our pledge to improving the health of Canadians through innovation and our support of Canadian healthcare professionals, patients and causes.”

About Bristol-Myers Squibb Canada

Bristol-Myers Squibb Canada is an indirect wholly-owned subsidiary of Bristol-Myers Squibb Company, a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. Bristol-Myers Squibb Canada is a leading provider of medicines to fight cancer, cardiovascular and metabolic disorders, infectious diseases (including HIV/AIDS), nervous system diseases and serious mental illness. Bristol-Myers Squibb Company is listed on the New York Stock Exchange under the BMY symbol (NYSE:BMY). Bristol-Myers Squibb Canada's operations are headquartered in Montréal, Québec.